Thermodynamic and structural effects of conformational constraints in protein-ligand interactions. Entropic paradoxy associated with ligand preorganization.
暂无分享,去创建一个
Stephen F Martin | John E DeLorbe | John H Clements | Martin G Teresk | Aaron P Benfield | Hilary R Plake | Laura E Millspaugh | J. H. Clements | John E Delorbe | Stephen F. Martin | M. Teresk | H. Plake | A. P. Benfield
[1] L. Amzel,et al. Compensating Enthalpic and Entropic Changes Hinder Binding Affinity Optimization , 2007, Chemical biology & drug design.
[2] R. Liskamp,et al. Cyclic phosphopeptides for interference with Grb2 SH2 domain signal transduction prepared by ring-closing metathesis and phosphorylation. , 2003, Organic & biomolecular chemistry.
[3] P. Bartlett,et al. Synthesis and Evaluation of Macrocyclic Transition State Analogue Inhibitors for α-Chymotrypsin , 2003 .
[4] P. Bartlett,et al. MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. 1. DESIGN, SYNTHESIS, AND EVALUATION OF AN INHIBITOR BRIDGED BETWEEN P1 AND P3 , 1998 .
[5] Bernhard Pfeiffer,et al. Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. , 2005, Chemical reviews.
[6] T. Creamer,et al. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. , 1996, Biochemistry.
[7] J. Schlessinger,et al. Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain , 1997, Journal of biomolecular NMR.
[8] J. Dunitz. The entropic cost of bound water in crystals and biomolecules. , 1994, Science.
[9] J. Kyte,et al. The basis of the hydrophobic effect. , 2002, Biophysical chemistry.
[10] P. Furet,et al. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. , 1998, Journal of molecular biology.
[11] J. Knowles,et al. Dehydroquinate synthase: a sheep in wolf's clothing? , 1989 .
[12] K. Shimamoto,et al. 2-(Carboxycyclopropyl)glycines: binding, neurotoxicity and induction of intracellular free Ca2+ increase. , 1992, European journal of pharmacology.
[13] G. Bodenhausen,et al. Thermodynamics of binding of 2-methoxy-3-isopropylpyrazine and 2-methoxy-3-isobutylpyrazine to the major urinary protein. , 2004, Journal of the American Chemical Society.
[14] S. Martin,et al. Structural and energetic aspects of Grb2-SH2 domain-swapping. , 2007, Archives of biochemistry and biophysics.
[15] D. Erdmann,et al. Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode , 1996, Nature Structural Biology.
[16] Thomas B. Sundberg,et al. Design and synthesis of conformationally constrained, extended and reverse turn pseudopeptides as Grb2-SH2 domain antagonists , 2003 .
[17] B. Roques,et al. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. , 2002, Journal of molecular biology.
[18] F. Diederich,et al. Interactions with aromatic rings in chemical and biological recognition. , 2003, Angewandte Chemie.
[19] W. DeGrado,et al. Template-constrained cyclic peptide analogues of somatostatin: subtype-selective binding to somatostatin receptors and antiangiogenic activity. , 2000, Bioorganic & medicinal chemistry.
[20] P. Kollman,et al. Solvation Model Based on Weighted Solvent Accessible Surface Area , 2001 .
[21] J. Ladbury. Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.
[22] Dagmar Ringe,et al. [19]Study of protein dynamics by X-ray diffraction , 1986 .
[23] Y. Ru,et al. Azepanone-based inhibitors of human and rat cathepsin K. , 2001, Journal of medicinal chemistry.
[24] G. Klebe,et al. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. , 2002, Angewandte Chemie.
[25] Dudley H. Williams,et al. The free energy change of restricting a bond rotation in the binding of peptide analogues to vancomycin group antibiotics , 1993 .
[26] J M Sturtevant,et al. Heat capacity and entropy changes in processes involving proteins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[27] Heather A Carlson,et al. Exploring experimental sources of multiple protein conformations in structure-based drug design. , 2007, Journal of the American Chemical Society.
[28] P. Rossky,et al. Hydration structure of the α-chymotrypsin substrate binding pocket: the impact of constrained geometry , 2000 .
[29] M. Stone,et al. NMR relaxation studies of the role of conformational entropy in protein stability and ligand binding. , 2001, Accounts of chemical research.
[30] H. Chuman,et al. Prediction of the 1-octanol/H2O partition coefficient, log P, by ab initio MO calculations: hydrogen-bonding effect of organic solutes on log P. , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[31] S. Martin,et al. Synthesis and properties of cyclopropane-derived peptidomimetics. , 2006, Accounts of chemical research.
[32] Arun K. Ghosh,et al. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. , 2005, Journal of medicinal chemistry.
[33] Michael Kahn,et al. 29 – DESIGN OF PEPTIDOMIMETICS , 2003 .
[34] Claudia S Maier,et al. Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain. , 2004, Biochimica et biophysica acta.
[35] D. G. Udugamasooriya,et al. Conformational constraint in protein ligand design and the inconsistency of binding entropy. , 2008, Biopolymers.
[36] L. Kay,et al. Correlation between binding and dynamics at SH2 domain interfaces , 1998, Nature Structural Biology.
[37] Mary C. Chervenak,et al. A Direct Measure of the Contribution of Solvent Reorganization to the Enthalpy of Binding , 1994 .
[38] Vincenzo Mollica,et al. Group contributions to the thermodynamic properties of non-ionic organic solutes in dilute aqueous solution , 1981 .
[39] R. Angeletti,et al. A transition-state analogue reduces protein dynamics in hypoxanthine-guanine phosphoribosyltransferase. , 2001, Biochemistry.
[40] R. Anderegg,et al. MASS SPECTROMETRIC CHARACTERIZATION OF A PROTEIN-LIGAND INTERACTION , 1995 .
[41] K. P. Murphy,et al. Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry. , 1996, Biophysical journal.
[42] D. Cram. Preorganization—From Solvents to Spherands , 1986 .
[43] Stephen Hanessian,et al. Design and synthesis of conformationally constrained amino acids as versatile scaffolds and peptide mimetics , 1997 .
[44] Michael K. Gilson,et al. Theory of free energy and entropy in noncovalent binding. , 2009, Chemical reviews.
[45] Michael K Gilson,et al. Host-guest complexes with protein-ligand-like affinities: computational analysis and design. , 2009, Journal of the American Chemical Society.
[46] H. Fukada,et al. Enthalpy and heat capacity changes for the proton dissociation of various buffer components in 0.1 M potassium chloride , 1998, Proteins.
[47] Charles A Laughton,et al. Strong solute-solute dispersive interactions in a protein-ligand complex. , 2005, Journal of the American Chemical Society.
[48] S. Martin,et al. Use of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide mimics in SH2 antagonists ☆ , 2000 .
[49] S. Martin,et al. Ligand preorganization may be accompanied by entropic penalties in protein-ligand interactions. , 2006, Angewandte Chemie.
[50] Ronald M. Levy,et al. The SGB/NP hydration free energy model based on the surface generalized born solvent reaction field and novel nonpolar hydration free energy estimators , 2002, J. Comput. Chem..
[51] P. Charifson,et al. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.
[52] C. Hunter,et al. Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox. , 2004, Angewandte Chemie.
[53] Reinskje Talhout,et al. Understanding binding affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin. , 2003, Journal of the American Chemical Society.
[54] Stefan Schmitt,et al. Do structurally similar ligands bind in a similar fashion? , 2006, Journal of medicinal chemistry.
[55] Jinfa Ying,et al. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor. , 2006, Journal of medicinal chemistry.
[56] Vladimir N Uversky,et al. Local Flexibility in Molecular Function Paradigm* , 2006, Molecular & Cellular Proteomics.
[57] J H Lakey,et al. Heat does not come in different colours: entropy-enthalpy compensation, free energy windows, quantum confinement, pressure perturbation calorimetry, solvation and the multiple causes of heat capacity effects in biomolecular interactions. , 2001, Biophysical chemistry.
[58] Richard Wolfenden,et al. Comparing the polarities of the amino acids: side-chain distribution coefficients between the vapor phase, cyclohexane, 1-octanol, and neutral aqueous solution , 1988 .
[59] J. Ferreon,et al. Ligand‐induced changes in dynamics in the RT loop of the C‐terminal SH3 domain of Sem‐5 indicate cooperative conformational coupling , 2003, Protein science : a publication of the Protein Society.
[60] E. Freire,et al. Overcoming Roadblocks in Lead Optimization: A Thermodynamic Perspective , 2006, Chemical biology & drug design.
[61] Shaomeng Wang,et al. A systematic analysis of the effect of small-molecule binding on protein flexibility of the ligand-binding sites. , 2005, Journal of medicinal chemistry.
[62] M. Vidal,et al. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs. , 2004, Journal of medicinal chemistry.
[63] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[64] Gabriel Waksman,et al. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding. , 2002, Journal of the American Chemical Society.
[65] T. Bhat,et al. Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors. , 1998, Journal of medicinal chemistry.
[66] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[67] Irene Luque,et al. Structural parameterization of the binding enthalpy of small ligands , 2002, Proteins.
[68] Gastone Gilli,et al. Enthalpy-entropy compensation in drug-receptor binding , 1994 .
[69] P. Ettmayer,et al. Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1). , 1999, Journal of medicinal chemistry.
[70] K. Ogura,et al. Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor , 2008, Journal of biomolecular NMR.
[71] M. Snow,et al. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2. , 1997, Biochemistry.
[72] T. Chalikian. Hydrophobic tendencies of polar groups as a major force in molecular recognition , 2003, Biopolymers.
[73] P. Bonneau,et al. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection. , 2003, Angewandte Chemie.
[74] M. Spaller,et al. Thermodynamic profiling of conformationally constrained cyclic ligands for the PDZ domain. , 2004, Bioorganic & medicinal chemistry letters.
[75] M. James,et al. Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes. , 1998, Biochemistry.
[76] S. Homans,et al. Water, water everywhere--except where it matters? , 2007, Drug discovery today.
[77] V. Hruby,et al. De Novo Design, Synthesis, and Biological Activities of High-Affinity and Selective Non-Peptide Agonists of the δ-Opioid Receptor‖ , 1998 .
[78] Gerhard Klebe,et al. What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .
[79] R. Angeletti,et al. Immucillin‐H binding to purine nucleoside phosphorylase reduces dynamic solvent exchange , 2000, Protein science : a publication of the Protein Society.
[80] S. Rosenberg,et al. 1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors. , 1992, Journal of medicinal chemistry.
[81] Min Zhou,et al. Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes. , 2004, Angewandte Chemie.
[82] J. Ladbury. Isothermal titration calorimetry: Application to structure-based drug design , 2001 .
[83] S. Liras,et al. Cyclopropanes as conformationally restricted peptide isosteres. Design and synthesis of novel collagenase inhibitors , 1993 .
[84] Qing-xiang Guo,et al. Isokinetic relationship, isoequilibrium relationship, and enthalpy-entropy compensation. , 2001, Chemical reviews.
[85] W. G. Hunter,et al. Statistical interpretation of enthalpy–entropy compensation , 1976, Nature.
[86] W. Gmeiner,et al. Hydrogen exchange shows peptide binding stabilizes motions in Hck SH2. , 1999, Biochemistry.
[87] G. Klebe. Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.
[88] G. Whitesides,et al. The paradoxical thermodynamic basis for the interaction of ethylene glycol, glycine, and sarcosine chains with bovine carbonic anhydrase II: an unexpected manifestation of enthalpy/entropy compensation. , 2006, Journal of the American Chemical Society.
[89] Andrew G. Leach,et al. Binding affinities of host-guest, protein-ligand, and protein-transition-state complexes. , 2003, Angewandte Chemie.
[90] T. Schumacher,et al. Specificity and affinity motifs for Grb2 SH2-ligand interactions , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[91] H. Schneider,et al. Stabilities of Hydrogen-Bonded Supramolecular Complexes with Various Numbers of Single Bonds: Attempts To Quantify a Dogma in Host-Guest Chemistry. , 1998, Angewandte Chemie.
[92] Horst Kessler,et al. Conformation and Biological Activity of Cyclic Peptides , 1982 .
[93] Paul A. Bartlett,et al. Structure-Based Design of an Inhibitor of the Zinc Peptidase Thermolysin , 1994 .
[94] K. Dill,et al. A View of the Hydrophobic Effect , 2002 .
[95] J D Dunitz,et al. Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions. , 1995, Chemistry & biology.
[96] R. S. Spolar,et al. Hydrophobic effect in protein folding and other noncovalent processes involving proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[97] P. Furet,et al. Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2. , 1998, Journal of medicinal chemistry.
[98] K. Sharp,et al. Entropy—enthalpy compensation: Fact or artifact? , 2001, Protein science : a publication of the Protein Society.
[99] D. Fairlie,et al. Beta-strand mimetics. , 2004, Chemical reviews.
[100] R. Panek,et al. Progress in the development of inhibitors of SH2 domains. , 2000, Current pharmaceutical design.
[101] J. M. Bradshaw,et al. Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide. , 1998, Biochemistry.
[102] Paul A. Bartlett,et al. Macrocyclic Inhibitors of Penicillopepsin. 3. Design, Synthesis, and Evaluation of an Inhibitor Bridged between P2 and P1‘ , 1998 .
[103] D. Williams,et al. An enthalpic component in cooperativity: the relationship between enthalpy, entropy, and noncovalent structure in weak associations. , 2001, Journal of the American Chemical Society.
[104] Gabriel Waksman,et al. Molecular recognition by SH2 domains. , 2002, Advances in protein chemistry.
[105] K. Parang,et al. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding. , 2004 .
[106] Kazuya Machida,et al. The SH2 domain: versatile signaling module and pharmaceutical target. , 2005, Biochimica et biophysica acta.
[107] Hans-Jörg Schneider,et al. Supramolecular Chemistry, Part 85[+] Flexibility, Association Constants, and Salt Effects in Organic Ion Pairs: How Single Bonds Affect Molecular Recognition , 1999 .
[108] Agnieszka Bronowska,et al. Global Changes in Local Protein Dynamics Reduce the Entropic Cost of Carbohydrate Binding in the Arabinose-binding Protein , 2007, Journal of molecular biology.
[109] P. Furet,et al. Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways. , 2000, Current pharmaceutical design.
[110] J. Onuchic,et al. Water mediation in protein folding and molecular recognition. , 2006, Annual review of biophysics and biomolecular structure.